Compound E, chemically designated as the compound 209986-17-4, represents a significant investigation within the field of Alzheimer's illness research. This γ-secretase inhibitor was initially developed as a https://alviniriq831487.aboutyoublog.com/51545679/γ-secretase-inhibitor-compound-e-209986-17-4